Kinnate Biopharma Inc. (KNTE)
NASDAQ: KNTE
· Real-Time Price · USD
2.65
-0.01 (-0.38%)
At close: Apr 02, 2024, 10:00 PM
Kinnate Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.06M | -30.73M | -31.92M | -32.94M | -31.56M | -30.74M | -27.07M | -26.9M | -26.16M | -24.7M | -21.45M | -17.46M |
Depreciation & Amortization | 198K | 197K | 201K | 203K | 190K | 184K | 172K | 58K | 36K | 28K | 28K | 31K |
Stock-Based Compensation | 3.83M | 5.28M | 5.4M | 5.4M | 4.94M | 4.98M | 4.88M | 4.78M | 4.3M | 4.16M | 3.76M | 2.79M |
Other Working Capital | 652K | 968K | 388K | -639K | -1.22M | 1.04M | -144K | -10K | -5.9M | 2.33M | -346K | 368K |
Other Non-Cash Items | 6.84M | -5.28M | -4.88M | -744K | -290K | 121K | 377K | 474K | 1.71M | 540K | 544K | 334K |
Deferred Income Tax | -8.03M | 3.94M | 3.74M | n/a | n/a | n/a | n/a | n/a | -1.19M | n/a | n/a | n/a |
Change in Working Capital | -3.15M | 1.06M | -1.97M | 357K | 2.97M | 4.79M | -1.9M | 506K | -1.22M | 2.33M | -346K | 857K |
Operating Cash Flow | -17.36M | -25.54M | -29.42M | -27.72M | -23.75M | -20.66M | -23.54M | -21.09M | -22.52M | -17.64M | -17.46M | -13.44M |
Capital Expenditures | n/a | n/a | 9K | -9K | -90K | -63K | -550K | -2.02M | -701K | -33K | -31K | -4K |
Cash Acquisitions | -9.13M | n/a | 10.89K | -55.43K | -17.66K | -17.02K | -23.83K | n/a | 33.77M | n/a | n/a | n/a |
Purchase of Investments | -19.15M | -29.32M | -73.15M | -33.1M | -45.45M | -38.56M | -18.94M | -73.58M | -30.53M | -14.97M | -32.01M | -169.63M |
Sales Maturities Of Investments | 41.85M | 71.95M | 62.26M | 88.53M | 63.1M | 55.58M | 42.77M | 10.96M | 33.57M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -10.89K | 55.43K | 17.66K | 17.02K | 23.83K | n/a | -33.77M | 33.77M | n/a | n/a |
Investing Cash Flow | 13.57M | 42.63M | -10.88M | 55.42M | 17.57M | 16.96M | 23.28M | -64.63M | 2.34M | 18.76M | -32.04M | -169.63M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.13M | 57K | 1.25M | -9.12M | 193K | 190K | 652K | 125K | 557K | 193K | 35.49M | n/a |
Financial Cash Flow | 9.13M | 57K | 1.25M | -9.12M | 193.00 | 190.00 | 652.00 | 125.00 | 557.00 | 193.00 | 35.49K | n/a |
Net Cash Flow | 5.34M | 17.16M | -39.06M | 18.58M | -5.99M | -3.51M | 388K | -85.59M | -19.63M | 1.31M | -14.02M | -183.07M |
Free Cash Flow | -17.36M | -25.54M | -29.41M | -27.73M | -23.84M | -20.72M | -24.09M | -23.1M | -23.22M | -17.67M | -17.49M | -13.45M |